Carregant...
The Promise of Novel Molecular Markers in Bladder Cancer
Bladder cancer is the fourth most common malignancy in the US and is associated with the highest cost per patient. A high likelihood of recurrence, mandating stringent surveillance protocols, has made the development of urinary markers a focus of intense pursuit with the hope of decreasing the burde...
Guardat en:
| Publicat a: | Int J Mol Sci |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4284796/ https://ncbi.nlm.nih.gov/pubmed/25535079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms151223897 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|